Shanghai Allist Pharmaceuticals Co., Ltd.
688578
Rank in Stocks
#3127
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese... Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Share Price
$12.65
Market Cap
$5.69B
Change (1 day)
-0.05%
Change (1 year)
-14.35%
Country
CN
Trade Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
Category
Healthcare
Operating Margin for Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
Operating Margin as of October 2026 TTM: 47.25%
According to Shanghai Allist Pharmaceuticals Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 47.25%. At the end of 2024 the company had an Operating Margin of 45.95%.
Operating Margin history for Shanghai Allist Pharmaceuticals Co., Ltd. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 47.25% | -5.12% |
| 2025 | 49.80% | 8.38% |
| 2024 | 45.95% | 40.99% |
| 2023 | 32.59% | 101.67% |
| 2022 | 16.16% | 292.23% |
| 2021 | 4.12% | -100.01% |
| 2020 | -55,350.13% | -8.58% |
| 2019 | -60,547.98% | 2,746.77% |
| 2018 | -2,126.90% | 323.58% |
| 2017 | -502.12% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -99.18% |
US
|
|
| -149.01% | -103.15% |
US
|
|
| 25.57% | -99.46% |
AU
|
|
| 31.23% | -99.34% |
BE
|
|
| 28.81% | -99.39% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.